Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases

In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necessary in the everyday clinical practice for the onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Tsiouda, Theodora, Trakada, Georgia, Kallianos, Anastasios, Veletza, Lemonia, Hatzibougias, Dimitris, Mihalopoulou, Electra, Goupou, Eirini, Kosmidis, Christoforos, Sardeli, Chrysanthi, Huang, Haidong, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519224/
https://www.ncbi.nlm.nih.gov/pubmed/28752057
http://dx.doi.org/10.1016/j.rmcr.2017.07.004
_version_ 1783251604537868288
author Zarogoulidis, Paul
Chinelis, Panos
Athanasiadou, Anastasia
Tsiouda, Theodora
Trakada, Georgia
Kallianos, Anastasios
Veletza, Lemonia
Hatzibougias, Dimitris
Mihalopoulou, Electra
Goupou, Eirini
Kosmidis, Christoforos
Sardeli, Chrysanthi
Huang, Haidong
Hohenforst-Schmidt, Wolfgang
author_facet Zarogoulidis, Paul
Chinelis, Panos
Athanasiadou, Anastasia
Tsiouda, Theodora
Trakada, Georgia
Kallianos, Anastasios
Veletza, Lemonia
Hatzibougias, Dimitris
Mihalopoulou, Electra
Goupou, Eirini
Kosmidis, Christoforos
Sardeli, Chrysanthi
Huang, Haidong
Hohenforst-Schmidt, Wolfgang
author_sort Zarogoulidis, Paul
collection PubMed
description In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necessary in the everyday clinical practice for the oncologic patient. Immunotherapy is nowadays the novel therapy for advanced stage non-small cell lung cancer with two agents nivolumab and pembrolizumab. In the current case series we will present adverse effects from our centers and comment on the treatment and follow-up of the patients.
format Online
Article
Text
id pubmed-5519224
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-55192242017-07-27 Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases Zarogoulidis, Paul Chinelis, Panos Athanasiadou, Anastasia Tsiouda, Theodora Trakada, Georgia Kallianos, Anastasios Veletza, Lemonia Hatzibougias, Dimitris Mihalopoulou, Electra Goupou, Eirini Kosmidis, Christoforos Sardeli, Chrysanthi Huang, Haidong Hohenforst-Schmidt, Wolfgang Respir Med Case Rep Case Report In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necessary in the everyday clinical practice for the oncologic patient. Immunotherapy is nowadays the novel therapy for advanced stage non-small cell lung cancer with two agents nivolumab and pembrolizumab. In the current case series we will present adverse effects from our centers and comment on the treatment and follow-up of the patients. Elsevier 2017-07-14 /pmc/articles/PMC5519224/ /pubmed/28752057 http://dx.doi.org/10.1016/j.rmcr.2017.07.004 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Zarogoulidis, Paul
Chinelis, Panos
Athanasiadou, Anastasia
Tsiouda, Theodora
Trakada, Georgia
Kallianos, Anastasios
Veletza, Lemonia
Hatzibougias, Dimitris
Mihalopoulou, Electra
Goupou, Eirini
Kosmidis, Christoforos
Sardeli, Chrysanthi
Huang, Haidong
Hohenforst-Schmidt, Wolfgang
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
title Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
title_full Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
title_fullStr Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
title_full_unstemmed Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
title_short Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
title_sort possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519224/
https://www.ncbi.nlm.nih.gov/pubmed/28752057
http://dx.doi.org/10.1016/j.rmcr.2017.07.004
work_keys_str_mv AT zarogoulidispaul possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT chinelispanos possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT athanasiadouanastasia possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT tsioudatheodora possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT trakadageorgia possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT kallianosanastasios possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT veletzalemonia possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT hatzibougiasdimitris possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT mihalopoulouelectra possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT goupoueirini possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT kosmidischristoforos possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT sardelichrysanthi possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT huanghaidong possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases
AT hohenforstschmidtwolfgang possibleadverseeffectsofimmunotherapyinnonsmallcelllungcancertreatmentandfollowupofthreecases

Ejemplares similares